MENU
Forex Education Symbols

(AGY.L)
28.125 -0.125 (-0.44%) 12-13 16:30
Open: 28.24 Prev Close: 28.25
High: 28.24 Low: 28
Volume: 16,358 Market Cap: 167M
Year High: 39.5 Year Low: 20.2
Stock Technical Analysis
Overall       
Targets Six months: 41.00    One year: 46.14
Supports Support1: 28.00   Support2: 23.30
Resistances Resistance1: 35.11    Resistance2: 39.50 
Pivot Point 28.80 
Moving Averages MA(5): 28.15      MA(20): 29.24 

MA(100): 31.54      MA(250): 28.228 
MACD MACD(12,26): -1.18      Signal(12,26,9): -1.23 
Stochastic Oscillator %K(14,3): 7.22      %D(3): 7.03 
RSI RSI(14): 30.52 
52-Week High: 39.50  Low: 20.50  Change(%): 36.4
Average Volume(K) 3-Month: 23718  10-Days: 13566.958984
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
AGY.L has closed above bottom band by 26.8%. Bollinger Bands are 36.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock News
Allergy Therapeutics teams up with Ergomed to take its anti-allergy tablets ...
Tue, 12 Dec 2017 08:39:50 GMT

Ergomed Plc adds to co-development pipeline with Allergy Therapeutics deal
Wed, 13 Dec 2017 15:33:45 GMT

Allergy Therapeutics: Trading Update
Tue, 18 Jul 2017 06:11:15 GMT

Allergy Therapeutics plc: Interim Results for the six months ended 31 December ...
Tue, 08 Mar 2016 07:07:30 GMT

Allergy Therapeutics plc (AIM:AGY): Is Now The Time To Bet On Healthcare?
Mon, 20 Nov 2017 17:15:00 GMT

Allergy Therapeutics PLC Announces Novel House Dust Mite Allergy Vaccine Gains ...
Tue, 14 Feb 2017 06:56:15 GMT

Stoxline Canada

Stock Chart London

Option Calculator

Financials
EPS
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Shares Out. (M) 1.15
Shares Float (M)
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Valuation
P/E -1.42
P/E Growth Ratio
P/BV
P/S
P/CF